<bill session="105" type="h" number="3462" updated="2013-07-14T18:50:46-04:00">
  <state datetime="1998-03-12">REFERRED</state>
  <status>
    <introduced datetime="1998-03-12"/>
  </status>
  <introduced datetime="1998-03-12"/>
  <titles>
    <title as="introduced" type="short">Drug and Device Recall Reporting Act of 1998</title>
    <title as="introduced" type="official">To amend the Federal Food, Drug, and Cosmetic Act to require notification of recalls of drugs and devices, and for other purposes.</title>
  </titles>
  <sponsor id="400370"/>
  <cosponsors>
    <cosponsor id="400553" joined="1998-03-27"/>
    <cosponsor id="400502" joined="1998-05-22"/>
    <cosponsor id="400227" joined="1998-03-12"/>
    <cosponsor id="400430" joined="1998-04-01"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1998-03-12">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="1998-03-23">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Consumer education"/>
    <term name="Defective products"/>
    <term name="Drug adulteration"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Drugstores"/>
    <term name="Fines (Penalties)"/>
    <term name="Government operations and politics"/>
    <term name="Law"/>
    <term name="Medical supplies"/>
    <term name="Pharmacists"/>
    <term name="Signs and signboards"/>
  </subjects>
  <amendments/>
  <summary>3/12/1998--Introduced.
Drug and Device Recall Reporting Act of 1998 - Amends the Federal Food, Drug, and Cosmetic Act to require a pharmacy that receives notice from a recalling firm of a Class I or Class II recall of a drug or device to notify retail customers that received the drug or device: (1) in writing, for customers receiving the drug or device on prescription; and (2) by public display, for all others. Mandates a civil monetary penalty for violations.</summary>
</bill>
